The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro Sleep Issues vs Wegovy — What the Evidence Shows
Sleep disturbances are reported by some people taking Mounjaro (tirzepatide) and Wegovy (semaglutide), though the frequency and severity vary between individuals. Both are prescription-only weight management injections licensed in the UK, but they work through different mechanisms — Mounjaro is a dual GIP and GLP-1 receptor agonist, whilst Wegovy is a GLP-1 agonist only. This guide compares how each medication may affect sleep based on clinical trial data and UK prescriber experience. If you're considering either treatment, use our free GLP-1 weight loss calculator to explore potential outcomes, and always discuss sleep concerns with your GP or prescriber.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Clinical Trial Data — Sleep and Mounjaro vs Wegovy
Mounjaro (tirzepatide) and sleep: In the SURMOUNT clinical trials, nausea, diarrhoea, and constipation were the most commonly reported side effects across all doses. Sleep disturbances were not listed as a primary or very common side effect in the published trial data, though some individuals report difficulty falling asleep or vivid dreams during the first few weeks of tirzepatide therapy.
Wegovy (semaglutide) and sleep: Similarly, the STEP-1 trial did not report sleep disturbances as a very common side effect. However, clinical experience in UK weight management services shows that some patients report either insomnia or unusual tiredness in the early stages of semaglutide treatment.
Why the difference? Both medications slow gastric emptying and alter appetite signalling. Changes in meal timing, reduced food intake, and initial nausea may indirectly affect sleep quality. The dual GIP mechanism of Mounjaro may theoretically influence energy metabolism differently than Wegovy's single GLP-1 pathway, though direct comparative data on sleep outcomes is limited.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Individual Factors and Prescriber Decision-Making
Sleep issues are highly individual and influenced by nausea severity, meal timing, caffeine intake, blood sugar control, and underlying sleep conditions. Neither Mounjaro nor Wegovy is contraindicated by a history of insomnia, but your prescriber will assess your personal risk factors during the clinical assessment.
If you experience sleep disturbances after starting either medication, contact your GP or prescriber before stopping treatment. Adjustments such as taking the injection at a different time of day, managing nausea with dietary changes, or dose modification may help. Our free progress tracker can help you log sleep quality alongside weight changes, providing useful information to share with your prescriber.
Both medications require a UK prescription following clinical assessment — neither is available over-the-counter or without professional guidance.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Does Mounjaro cause sleep problems more than Wegovy?
Clinical trial data does not show sleep disturbances as a common side effect of either medication. Individual reports vary. Both work through appetite-regulating hormones that can indirectly affect sleep via changes in meal timing and nausea. Your prescriber will assess which is more suitable based on your personal health profile and tolerance.
What should I do if I can't sleep after starting Mounjaro or Wegovy?
Contact your GP or prescriber before stopping treatment. Sleep issues often improve after the first few weeks. Your prescriber may suggest adjusting injection timing, managing nausea with dietary changes, or temporarily modifying your dose. Keep a sleep log to share with your healthcare team.
Is Mounjaro or Wegovy better if I have a sleep condition like sleep apnoea?
Both GLP-1 and GIP/GLP-1 medications may actually improve sleep apnoea symptoms through weight loss. However, if you have a pre-existing sleep disorder, your prescriber must assess your suitability during the clinical assessment. This is essential information to disclose.
Can I take Mounjaro or Wegovy if I take sleeping tablets?
Possibly, but your prescriber must know about all medications you take, including sleep aids. Some interactions are possible. Always disclose all medications during your clinical assessment — whether NHS or private prescription.
How long do sleep issues last on Mounjaro or Wegovy?
Most side effects, including sleep disturbances, are typically temporary and improve within the first 4–8 weeks as your body adjusts. If sleep problems persist beyond 8 weeks, contact your prescriber. Your GP can offer guidance specific to your situation.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.